Skip to search Skip to main content

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)

https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-017.html

 

Limited Submission Program (LSP): This funding opportunity and the Limited Submission Program (LSP) is open to all Texas A&M University faculty and principal investigators who meet the eligibility requirements. Texas A&M and The Texas A&M University System agencies jointly administer this process to select the proposal(s) that will be submitted to the sponsor in response to this solicitation.

 

Institutional Eligibility:  Only one application per institution is allowed.

 

PI Eligibility:  Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

 

The proposal will be prepared and submitted by Sponsored Research Services (SRS).

 

Proposal Limit: 1

 

Summary:  The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC), in collaboration with the International IBD Genetics Consortium, has identified about 200 susceptibility loci for IBD.  The IBDGC has recently been awarded renewed funding to identify causal genes and genetic variants within these loci, and to elucidate the mechanisms through which they contribute to the pathophysiology of IBD.  However, the IBDGC's current resources permit them to explore the functions of only a limited set of genes within a limited set of physiological domains.  The purpose of this Funding Opportunity Announcement (FOA) is to expand the number of genes and range of IBD-related phenotypes and physiological domains under study by means of collaborations of the IBDGC with investigators with expertise complementary to that of their own members.  Proposed studies must not duplicate studies either ongoing or already completed by the IBDGC.  Multi-site clinical trials will not be considered responsive to this FOA.

 

Dates:

 

November 27, 2018

Deadline for an email of intent including the title of the internal proposal and a one to three sentence description of the project. 

 

Send email of intent to limitedsubmissions@tamu.edu

December 4, 2018

Deadline to submit an internal proposal.

 

All proposals for the LSP must be submitted electronically using the e-proposal on-line application system.

 

Be prepared to upload your internal proposal. The sections will include a one-three page research plan summary, two-page bio-sketch (per PI), and preliminary budget.

 

The e-proposal site is password protected. Texas A&M principal investigators may use their NetID and password to access the system. If you do not have a NetID, click HERE for help to activate your NetID. You will need your UIN and your date of birth.  Once you log-in to e-proposal, choose “Limited Submission Grant” from the Available Grants section.


If you have any questions, please contact:

 shelly.martin@tamu.edu  or 979.862.2233.

 

January 8, 2018

Target date for the notifications to PIs of the result of the internal competition.

February 21, 2019

Sponsor deadline for the full proposal.

 

 

Internal Selection Procedures:

Texas A&M has established a procedure to identify limited submission opportunities and internally select proposals for Texas A&M submissions.  Please contact us if you have any questions about the limited submission process.